Andrés Villabona-Rueda (@andrviru) header
Andrés Villabona-Rueda (@andrviru) profile picture

IM PGY-1 @FIUMedicine | Former Scientist @Umiamimedicine and research fellow @Hopkinsmedicine 🇺🇸 | MD @UIS 🇨🇴 | He/Him/His | 🩺🏥 🧬 🏃🏻 ✈️

Miami, FL
Joined May 2011
Photo by Andrés Villabona-Rueda (@andrviru)Photo by Andrés Villabona-Rueda (@andrviru)Photo by Andrés Villabona-Rueda (@andrviru)Photo by Andrés Villabona-Rueda (@andrviru)Photo by Andrés Villabona-Rueda (@andrviru)Photo by Andrés Villabona-Rueda (@andrviru)Photo by Andrés Villabona-Rueda (@andrviru)Photo by Andrés Villabona-Rueda (@andrviru)Photo by Andrés Villabona-Rueda (@andrviru)Photo by Andrés Villabona-Rueda (@andrviru)
Andrés Villabona-Rueda retweeted
Among adults with septic shock, the use of restricted fluids and early vasopressors did not result in more days alive and out of the hospital through day 90 than the use of liberal fluids and later vasopressors. Full ARISE FLUIDS trial results and Research Summary: nej.md/3PVdwIp
8
93
5
316
41,615
Andrés Villabona-Rueda retweeted
Use this free patient summary to help explain the new U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for #tobacco use treatment. bit.ly/3VLhCoM
1
6
8
1,955
Andrés Villabona-Rueda retweeted
Original research findings indicate that the ventilator-associated pneumonia (VAP) risk score allows daily stratification of VAP risk in patients receiving ventilation for ≥ 48 hours using six clinical variables. Read more in #Journal_CHESTCritCare: hubs.la/Q04w4q5_0 #MedEd #JournalCHEST #CriticalCare #CritCare #Pneumonia
1
10
16
1,579
Andrés Villabona-Rueda retweeted
📣 Sepsis Webinar in Spanish Join CHEST and the Asociación Latinoamericana de Tórax Monday, September 21, at 6 pm CT, for a Spanish-language webinar on the latest in sepsis and ARDS. English captions available 🔗Register: hubs.la/Q04xHkxW0
4
3
1,224
Andrés Villabona-Rueda retweeted
Skin diseases affect far more than what we can see. A new Editorial examines how advances in dermatology can deliver greater clinical benefit—from more representative clinical trials to better measurement of stigma and quality of life. Read this & more: spkl.io/601973DaJ
3
58
5
123
42,368
Andrés Villabona-Rueda retweeted
A new Annals #InTheClinic feature outlines evidence-based strategies for health care maintenance in the outpatient management of adults with #InflammatoryBowelDisease. bit.ly/4wT4hbR
1
4
20
2,469
Andrés Villabona-Rueda retweeted
Syncope, or a fainting episode, is defined as a transient loss of consciousness accompanied by an inability to maintain postural tone, resulting from temporary cerebral hypoperfusion, which is followed by rapid and spontaneous recovery. Learn more in a new article: nej.md/4cjFuVU
15
1
67
33,669
Closing an unforgettable 8-year chapter with my research family 🥹 from Johns Hopkins to the University of Miami. Thank you for everything 🙏🏼 Excited for the next chapter #Medicine #Science @DAlessioLab @RDamicoJHHPH
1
7
282
Andrés Villabona-Rueda retweeted
📆📆📆Part 2 of the ATS AII Abstract scholarship awardee presentations is coming up fast. Use the ATS website to register now! See you on 10/17/25 at 1100EST! @ATS_Assemblies @atscommunity
1
1
3
781
Andrés Villabona-Rueda retweeted
Patterns of nodularity on CT from our most recent Fellows' Case Files from KUMC pulmpeeps.com/2025/10/01/107… Apple: podcasts.apple.com/us/podcas… Spotify: open.spotify.com/episode/75D… Amazon: music.amazon.com/podcasts/91…
84
309
16,959
Andrés Villabona-Rueda retweeted
BREAKING NEWS The 2025 #NobelPrize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”
454
11,577
1,520
28,136
4,272,297
Excited to share our translational burn pit model at #ATS2025—helping uncover how macrophages drive disease progression and opening doors for new therapeutic targets in deployment-related chronic bronchitis (DRCB). Grateful to @ATS_AII for sparking such a dynamic discussion!
Third and last presentation of @ATS_AII Abstract Scholarship Awardees part one #burnpit
1
2
510
Andrés Villabona-Rueda retweeted
Breathe: Idiopathic pulmonary fibrosis and progressive pulmonary fibrosis are characterised by progressive fibrosis and share common pathophysiological pathways that have led to the study of promising new therapeutic targets. bit.ly/3RdJRqA
1
47
1
93
6,483
Andrés Villabona-Rueda retweeted
The Heterogeneity, Parallels, and Divergence of Alveolar Macrophages in Humans and Mice @atscommunity 🔗 tinyurl.com/yb66ch6e
1
2
496
Andrés Villabona-Rueda retweeted
International Medical Graduates Are Integral to the Delivery of Patient Care in the United States | Annals of Internal Medicine acpjournals.org/doi/10.7326/…
1
9
383
Special Stains in Histopathology 🔬 polysciences.com/german/cata…
4
136
3
384
38,800
Andrés Villabona-Rueda retweeted
31
762
125
2,235
281,525
And here we are! Doing science until the very last day! Will miss this awesome crew (this centrifuge of course ) 🤣 @romyrod @DrGhanbar #Physician #Scientist #Pulmonary #Medicine #Hopkins #PCCM
3
22
2,237
A well deserved coffee after multiple poster presentations at ATS. Such a busy day! ☕️ #CoffeeLovers #LatinoEnUSA #IMGs @romyrod @HopkinsPCCM @JHUPCCMFellows
2
23
958
Excited to share our preliminary results related to the different gene and protein signature of alveolar and bone marrow derived macrophages at ATS! 🫁 #Physician #Scientist #Medicine @RDamicoJHHPH @DAlessioLab @JHUPCCMFellows @HopkinsMedicine
Amazing work by @andrviru on Transcriptomic Signatures in Alveolar and Bone-Derived Macrophages #ATS2024
1
16
704